Antiangiogenic Drug Combination TL-118

**Semantic type:** Pharmacologic Substance

**Definition:** A proprietary, oral suspension containing a combination of agents comprised of a nonsteroidal anti-inflammatory agent, an alkylating agent, a histamine H2 antagonist and a sulfonamide with potential anti-angiogenic and antineoplastic activities. Antiangiogenic drug combination TL-118 is administrated as a specific dosing regimen and may result in a synergistic effect and reduce angiogenesis and inhibit tumor cell proliferation.

**Synonyms:** - Hamsa-1 - TL-118